{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:46:00Z","timestamp":1789573560843,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL141891"],"award-info":[{"award-number":["R01HL141891"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL151776"],"award-info":[{"award-number":["R01HL151776"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jtcvsopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTCVS Open"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.xjon.2022.05.013","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T02:12:21Z","timestamp":1653963141000},"page":"92-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Poor long-term outcomes of intravenous drug users with infectious endocarditis"],"prefix":"10.1016","volume":"11","author":[{"given":"Juan","family":"Caceres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroosa","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroma","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Clemence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Makkinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xjon.2022.05.013_bib1","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0003-4975(00)01139-5","article-title":"Surgery for active culture-positive endocarditis: determinants of early and late outcome","volume":"69","author":"Alexiou","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.xjon.2022.05.013_bib2","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/hrt.2005.067256","article-title":"The changing face of infective endocarditis","volume":"92","author":"Prendergast","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.xjon.2022.05.013_bib3","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.2017.4287","article-title":"Trends in infective endocarditis in California and New York State, 1998-2013","volume":"317","author":"Toyoda","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.xjon.2022.05.013_bib4","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.jacc.2015.03.518","article-title":"Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011","volume":"65","author":"Pant","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.xjon.2022.05.013_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/j.semtcvs.2018.07.016","article-title":"Recidivism is the leading cause of death among intravenous drug users who underwent cardiac surgery for infective endocarditis","volume":"31","author":"Nguemeni Tiako","year":"2019","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.xjon.2022.05.013_bib6","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers\u2014United States, 1999-2008","volume":"60","author":"Paulozzi","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.xjon.2022.05.013_bib7","doi-asserted-by":"crossref","first-page":"e012969","DOI":"10.1161\/JAHA.119.012969","article-title":"Geographic trends, patient characteristics, and outcomes of infective endocarditis associated with drug abuse in the United States from 2002 to 2016","volume":"8","author":"Kadri","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.xjon.2022.05.013_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.athoracsur.2006.07.037","article-title":"Long-term outcomes in valve replacement surgery for infective endocarditis","volume":"83","author":"Kaiser","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.xjon.2022.05.013_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.athoracsur.2011.08.016","article-title":"Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users","volume":"93","author":"Rabkin","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.xjon.2022.05.013_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jbi.2015.05.003","article-title":"Supporting information retrieval from electronic health records: a report of University of Michigan's nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE)","volume":"55","author":"Hanauer","year":"2015","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.xjon.2022.05.013_bib12","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1360-0443.2007.02118.x","article-title":"Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs)","volume":"103","author":"Conner","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.xjon.2022.05.013_bib13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1055\/s-0037-1618578","article-title":"Treatment outcomes for right-sided endocarditis in intravenous drug users: a systematic review and analysis of outcomes in a tertiary centre","volume":"66","author":"Magsino","year":"2018","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.xjon.2022.05.013_bib14","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/cid\/ciy1064","article-title":"Drug use and postoperative mortality following valve surgery for infective endocarditis: a systematic review and meta-analysis","volume":"69","author":"Hall","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xjon.2022.05.013_bib15","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.athoracsur.2020.03.089","article-title":"The evolving burden of drug use associated infective endocarditis in the United States","volume":"110","author":"Geirsson","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.xjon.2022.05.013_bib16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.athoracsur.2015.03.019","article-title":"Injection drug use and outcomes after surgical intervention for infective endocarditis","volume":"100","author":"Shrestha","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.xjon.2022.05.013_bib17","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/CIRCULATIONAHA.119.044913","article-title":"Incidence, microbiology, and outcomes in patients hospitalized with infective endocarditis","volume":"141","author":"Shah","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.xjon.2022.05.013_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amjmed.2019.08.022","article-title":"Clinical practice update on infectious endocarditis","volume":"133","author":"El-Dalati","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.xjon.2022.05.013_bib19","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jtcvs.2016.09.093","article-title":"2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: surgical treatment of infective endocarditis: executive summary","volume":"153","author":"Pettersson","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.xjon.2022.05.013_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.athoracsur.2021.02.027","article-title":"The clinical impact of implementation of a multidisciplinary endocarditis team","volume":"113","author":"El-Dalati","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.xjon.2022.05.013_bib21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10096-019-03776-9","article-title":"Physician perceptions of a multidisciplinary endocarditis team","volume":"39","author":"El-Dalati","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.xjon.2022.05.013_bib22","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.amjcard.2013.05.060","article-title":"Impact of a multidisciplinary management strategy on the outcome of patients with native valve infective endocarditis","volume":"112","author":"Chirillo","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.xjon.2022.05.013_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.amjmed.2015.09.024","article-title":"Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis","volume":"129","author":"Rosenthal","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.xjon.2022.05.013_bib24","article-title":"A step-by-step guide to implementing a multidisciplinary endocarditis team","volume":"8","author":"El-Dalati","year":"2021","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.xjon.2022.05.013_bib25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/cid\/ciz804","article-title":"Infectious complications of addiction: a call for a new subspecialty within infectious diseases","volume":"70","author":"Serota","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xjon.2022.05.013_bib26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2459\/JCM.0b013e32835ec585","article-title":"Management of patients with infective endocarditis by a multidisciplinary team approach: an operative protocol","volume":"14","author":"Chirillo","year":"2013","journal-title":"J Cardiovasc Med"}],"container-title":["JTCVS Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266627362200239X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266627362200239X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:47:43Z","timestamp":1762980463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266627362200239X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":25,"alternative-id":["S266627362200239X"],"URL":"https:\/\/doi.org\/10.1016\/j.xjon.2022.05.013","relation":{},"ISSN":["2666-2736"],"issn-type":[{"value":"2666-2736","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poor long-term outcomes of intravenous drug users with infectious endocarditis","name":"articletitle","label":"Article Title"},{"value":"JTCVS Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xjon.2022.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery.","name":"copyright","label":"Copyright"}]}}